Company profileSME (from the award notice)

G.L. Pharma Deutschland GmbH

Legal form: GmbH
Seat: Hamburg, Germany

Based on the notices and sources Inteliwert covers; not a complete record. Last checked 16 September 2026.

Identifiers

Not found in the indexed notices.

Track record in public tenders

Awards in the covered notices over the last 36 months, per CPV division.

No award found in the indexed notices of the last 36 months.

Awards

Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130a Abs. 8 SGB V zwischen der IKK classic und der G.L. Pharma Deutschland GmbH zu RemosanBuyer: IKK classic · Award value: €1 excl. VAT · Awarded: 16 September 2026 · CPV 33600000

Certifications and prequalification

No certification or prequalification found in the covered sources.

A certification missing here is unknown, not absent.

Website and LinkedIn

Not found in the indexed notices.

Open tenders that might fit

Possible match based on public information

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

OpenTenderSME (from the award notice)New to public tenders

Open-House-Rabattverträge 2026-12

Buyer
Techniker Krankenkasse
Place
DE600 (Hamburg)
Deadline
31 Aug 2028, 23:58 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 20:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Open-House-Originale-Rabattverträge 2026-13 Etrasimod

Buyer
Techniker Krankenkasse
Place
DE600 (Hamburg)
Deadline
31 Oct 2028, 23:58 (UTC+01:00)

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- Seat in the same district as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 13:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Thalidomid, ATC L04AX02 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)

Buyer
DAK-Gesundheit
Deadline
5 Sept 2029, 12:00 (UTC+02:00)
Published value
€1 excl. VAT

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- The contract value is close to the values of its past awards Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 13:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nadroparin, ATC B01AB06 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)

Buyer
DAK-Gesundheit
Deadline
5 Sept 2029, 12:00 (UTC+02:00)
Published value
€1 excl. VAT

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- The contract value is close to the values of its past awards Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 13:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Cinacalcet (ausschl. in der Normgröße N3), ATC H05BX01 f. d. Z. 01.11.26-31.10.28 (zzgl. V.-Option 1x12 Mon)

Buyer
DAK-Gesundheit
Deadline
5 Sept 2029, 12:00 (UTC+02:00)
Published value
€1 excl. VAT

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- The contract value is close to the values of its past awards Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 13:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus (ATC-Code nach WHO: L04AD02), mit Einschränkung auf die Darreichung

Buyer
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Place
DED21 (Sachsen)
Deadline
31 Oct 2027, 23:58 (UTC+01:00)

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus (ATC-Code nach WHO: L04AD02)

Buyer
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
Place
DED21 (Sachsen)
Deadline
31 Oct 2027, 23:58 (UTC+01:00)

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Abschluss nicht-exklusiver Rabattvereinbarungen nach §130a Abs.8 SGB V zu verschiedenen Wirkstoff-/en/-kombinationen mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. Open House-Verfahrens

Buyer
AOK Nordost. Die Gesundheitskasse.
Place
DE404 (Brandenburg)
Deadline
5 Mar 2028, 23:58 (UTC+01:00)

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 18:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Arzneimittelverträge mit Beitrittsoption für den Wirkstoff: Cyanocobalamin (OTC, parenteral)

Buyer
BARMER Beschaffung und Vergabe
Place
DEA1A (Nordrhein-Westfalen)
Deadline
1 Aug 2028, 12:00 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 13:30 (UTC+01:00)Official notice
OpenTenderSME (from the award notice)New to public tenders

Arzneimittel mit dem Wirkstoff Perampanel (ATC: N03AX22)

Buyer
AOK Sachsen - Anhalt
Place
DEE03 (Sachsen-Anhalt)
Deadline
31 Aug 2028, 00:00 (UTC+02:00)

Reasons
- Won a contract in CPV group 336 (2026-09-16) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 20:30 (UTC+01:00)Official notice

Is this your company?

Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.

About this profile

Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.

Based on the notices and sources Inteliwert covers; not a complete record.

Last checked 16 September 2026.

Markdown version